Bharat Biotech launches oral vaccine for Cholera
Hyderabad: Bharat Biotech International Limited has announced the global launch of Hillchol, a novel oral cholera vaccine. The company has ...
Hyderabad: Bharat Biotech International Limited has announced the global launch of Hillchol, a novel oral cholera vaccine. The company has ...
Hyderabad: The world's first intranasal heterologous booster dose has begun to be dispatched by Bharat Biotech to hospitals, Executive Chairman ...
New Delhi: The Government has launched Bharat Biotech's nasal Covid vaccine, iNCOVACC, The world's first made-in-India intranasal vaccine was launched ...
The two major Hyderabad-based vaccine manufacturing units, Biological E and Bharat Biotech, together are holding about 250 million Covid vaccine ...
New Delhi: India's fight against Covid 19 virus to get stronger. An expert panel has given its nod to use ...
Bharat Biotech's Covaxin is 77.8% effective and offers 65.2 per cent protection against rapidly emerging Delta variant, the vaccine maker ...
Hyderabad: Ocugen and Bharat Biotech have entered into an amendment to their Co-development, Supply, and Commercialization Agreement to expand Ocugen’s ...
Hyderabad: Bharat Biotech Head of Business Development and International Advocacy, Dr Raches Ella held a virtual interaction with FICCI Ladies ...
New Delhi: Bharat Biotech on Tuesday said it will continue the steady supply of its COVID-19 vaccine Covaxin, adding the ...
• Capacity expansion has been implemented across multiple facilities in Hyderabad and Bangalore, to reach ~ 700 million doses / ...